Literature DB >> 2583200

Measured attenuation correction methods.

H Ostertag1, W K Kübler, J Doll, W J Lorenz.   

Abstract

Accurate attenuation correction is a prerequisite for the determination of exact local radioactivity concentrations in positron emission tomography. Attenuation correction factors range from 4-5 in brain studies to 50-100 in whole body measurements. This report gives an overview of the different methods of determining the attenuation correction factors by transmission measurements using an external positron emitting source. The long-lived generator nuclide 68Ge/68Ga is commonly used for this purpose. The additional patient dose from the transmission source is usually a small fraction of the dose due to the subsequent emission measurement. Ring-shaped transmission sources as well as rotating point or line sources are employed in modern positron tomographs. By masking a rotating line or point source, random and scattered events in the transmission scans can be effectively suppressed. The problems of measured attenuation correction are discussed: transmission/emission mismatch, random and scattered event contamination, counting statistics, transmission/emission scatter compensation, transmission scan after administration of activity to the patient. By using a double masking technique simultaneous emission and transmission scans become feasible.

Entities:  

Mesh:

Year:  1989        PMID: 2583200     DOI: 10.1007/bf00631764

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  5 in total

1.  Super PETT I: A Positron Emission Tomograph Utilizing Photon Time-of-Flight Information.

Authors:  M M Ter-Pogossian; D C Ficke; M Yamamoto; J T Hood
Journal:  IEEE Trans Med Imaging       Date:  1982       Impact factor: 10.048

2.  Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction.

Authors:  S C Huang; E J Hoffman; M E Phelps; D E Kuhl
Journal:  J Comput Assist Tomogr       Date:  1979-12       Impact factor: 1.826

3.  A method for postinjection PET transmission measurements with a rotating source.

Authors:  R E Carson; M E Daube-Witherspoon; M V Green
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

4.  Performance characteristics of Positologica III: a whole-body positron emission tomograph.

Authors:  M Senda; N Tamaki; Y Yonekura; S Tanada; K Murata; N Hayashi; T Fujita; H Saji; J Konishi; K Torizuka
Journal:  J Comput Assist Tomogr       Date:  1985 Sep-Oct       Impact factor: 1.826

5.  Design and evaluation of a positron emission tomograph: HEADTOME III.

Authors:  I Kanno; S Miura; S Yamamoto; H Iida; M Murakami; K Takahashi; K Uemura
Journal:  J Comput Assist Tomogr       Date:  1985 Sep-Oct       Impact factor: 1.826

  5 in total
  5 in total

Review 1.  PET/MRI hybrid imaging: devices and initial results.

Authors:  Bernd J Pichler; Martin S Judenhofer; Hans F Wehrl
Journal:  Eur Radiol       Date:  2008-03-21       Impact factor: 5.315

Review 2.  Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging?

Authors:  Bernd J Pichler; Hans F Wehrl; Armin Kolb; Martin S Judenhofer
Journal:  Semin Nucl Med       Date:  2008-05       Impact factor: 4.446

3.  A hybrid method of attenuation correction for positron emission tomography brain studies.

Authors:  V Bettinardi; M C Gilardi; S Cargnel; G Rizzo; M Teräs; G Striano; F Fazio
Journal:  Eur J Nucl Med       Date:  1994-12

4.  Assessment of attenuation correction for myocardial PET imaging using combined PET/MRI.

Authors:  Martin Lyngby Lassen; Sazan Rasul; Dietrich Beitzke; Marie-Elisabeth Stelzmüller; Jacobo Cal-Gonzalez; Marcus Hacker; Thomas Beyer
Journal:  J Nucl Cardiol       Date:  2017-11-22       Impact factor: 5.952

5.  Reproducibility of Quantitative Brain Imaging Using a PET-Only and a Combined PET/MR System.

Authors:  Martin L Lassen; Otto Muzik; Thomas Beyer; Marcus Hacker; Claes Nøhr Ladefoged; Jacobo Cal-González; Wolfgang Wadsak; Ivo Rausch; Oliver Langer; Martin Bauer
Journal:  Front Neurosci       Date:  2017-07-17       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.